Search the Newsreel

FedEx Corporation $FDX Shares Purchased by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in FedEx Corporation (FDX) by 15.9% in the second quarter, bringing its total holdings to 25,299 shares valued at approximately $7.9 million. Other institutional investors also adjusted their positions, and 84.47% of FedEx stock is now owned by institutional …

Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX

Seilern Investment Management Ltd increased its stake in IDEXX Laboratories, Inc. by 20.7% in the second quarter, purchasing an additional 16,729 shares. The firm now holds 97,560 shares valued at approximately $51.4 million, making IDEXX its fifth-largest position. IDEXX Laboratories reported strong quarterly results, …

Addex Therapeutics (0QNV) Q1 2026 Earnings Report - Results, Call & Slides

California State Teachers Retirement System Boosts Position in Standex International Corporation $SXI

The California State Teachers Retirement System increased its stake in Standex International Corporation by 26.5% during the first quarter, bringing its total holdings to 14,604 shares valued at $3.72 million. Institutional investors collectively own 90.35% of the company, which recently exceeded earnings expectations with …

Celldex Therapeutics (CLDX) Stock Looks Rich On Book Value But Strong On Returns

IDEXX Laboratories Inc (HAM:IX1) Stock Price & 30 Year Financial Data

This article provides comprehensive 30-year financial data for IDEXX Laboratories Inc (HAM:IX1), including growth rates for revenue, EPS, EBIT, EBITDA, and free cash flow. It details key financial metrics such as Market Cap, Enterprise Value, PE Ratio, PB Ratio, and GF Score, offering an …

Celldex Therapeutics (CLDX) Could Be 130% Undervalued After Second Quarter Results

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Celldex Therapeutics (CLDX) released its second quarter 2026 results on 6 August, reporting very limited revenue and a wider net loss. This places the stock's …

Is Celldex Therapeutics’ (CLDX) Growing Losses With Minimal Revenue a Strategic Bet or Structural Concern?

Celldex Therapeutics, Inc. recently reported second-quarter 2026 results, with revenue falling to US$0.022 million and net loss widening to US$73.5 million, while loss per share from continuing operations increased to US$0.94. Over the first half of 2026, revenue slipped to just US$0.037 million as …

Celldex Therapeutics (CLDX) Stock Trades At A Premium Despite A 102% Return

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Celldex Therapeutics stock has more than doubled over the past year, yet its broader valuation checks lean expensive rather than cheap, which raises …

What Is Celldex Therapeutics (CLDX) Signaling With Its Mixed Pipeline Update?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Celldex Therapeutics (NasdaqCM:CLDX) reported updated clinical pipeline data, including positive Phase 1 results for bispecific antibody CDX-622. The company outlined progress on ongoing Phase 3 …

Addex Therapeutics Ltd (ADXN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Addex Therapeutics Ltd (ADXN), noting that no earnings forecast score is currently available, contrasting with the industry average. It highlights an analyst-rated target price of $30.00, suggesting a significant upside. The report also includes peer comparisons for …

IDEXX Labs posts 9% organic growth, raises EPS forecast, driven by global diagnostic expansion.

IDEXX Laboratories reported a 9% organic revenue growth in Q2 2026 and has subsequently increased its EPS guidance to $14.69–14.94, driven by strong demand for its veterinary diagnostic products. While growth in the US market is decelerating, significant long-term potential is seen in international …

DexCom, Inc. $DXCM Stock Position Lifted by Gradient Investments LLC

Gradient Investments LLC increased its stake in DexCom, Inc. (NASDAQ:DXCM) by 16.7% in the second quarter, bringing its total holdings to 372,542 shares valued at approximately $25.1 million. DexCom recently reported strong quarterly earnings, beating expectations with $0.70 EPS and a 13.1% year-over-year revenue …

DexCom, Inc. $DXCM Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in DexCom (NASDAQ:DXCM) by 96.5% in the first quarter, selling 948,754 shares and retaining 34,025 shares. Despite this, institutional investors and hedge funds still own 97.75% of the company, and analyst sentiment remains positive with a "Moderate …

FedEx Freight Holding Company (FDXF) sees 19.9% stake held by FedEx Corp

FedEx Corporation has reported a 19.9% beneficial ownership stake in FedEx Freight Holding Company, Inc. (FDXF), amounting to 29,751,545 shares. This ownership gives FedEx Corporation sole voting and dispositive power over these shares. The filing, a Schedule 13G, indicates a significant minority position based …

IDEXX Laboratories, Inc. (IDXX) stock price, news, quote and history

This article provides a comprehensive overview of IDEXX Laboratories, Inc. (IDXX) stock, including its current price, key financial statistics, historical performance, and analyst ratings. It details the company's operations in animal diagnostics, water quality, and veterinary software, and compares its performance to benchmarks like …

Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX

Aurora Investment Managers LLC. has acquired a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX), purchasing 4,638 shares valued at approximately $2.44 million. This investment makes IDEXX Laboratories the 21st largest position in Aurora Investment Managers' portfolio, representing 1.5% of its total investments. The article …

Notícias das Ações da IDEXX Laboratories Inc (IDXX)

Celldex Therapeutics (NASDAQ:CLDX) Issues Earnings Results, Beats Estimates By $0.12 EPS

Celldex Therapeutics, Inc. Stock 12‑Month Price Target Raised to $58.07, Implies 40% Upside

The average 12-month price target for Celldex Therapeutics, Inc. (CLDX) stock has been raised from $57.07 to $58.07 by 15 analysts, with individual forecasts ranging from $38 to $100 per share. This new target suggests a potential upside of approximately 40% based on the …

Standex (SXI) Q4 2026 Earnings Call Transcript

Standex (SXI) reported record Q4 2026 earnings, with net sales growing 7.7% organically to $228.3 million and adjusted EPS reaching $2.45. The company is strategically focusing on expanding its grid business capacity, aiming for $340 million to $440 million in annual sales by fiscal …

Standex International (SXI) Is Up 14.7% After Strong FY 2026 Earnings And 2027 Growth Outlook

Standex International Corp (SXI) Shares Surge 3.4% -- What GF Sc

Standex International Corp (SXI) shares rose 3.4% to $337.63. GuruFocus indicates the stock is significantly overvalued by 53.1% based on its GF Value™ estimate of $220.55. The company has a GF Score™ of 68/100, showing strong profitability but lower growth and valuation ranks, and …

IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for IRIDEX Corp (IRIX), indicating a current earnings forecast score of 8.00 and a "Buy" rating based on one analyst. It details future revenue and EPS expectations, with an anticipated next-quarter revenue of $12.98 million and an EPS …

FEDEX CORP (NYSE: FDX) COO reshapes family-linked share reporting

FedEx COO Richard W. Smith has updated his beneficial ownership reporting, reclassifying 253,927 common shares previously linked to a family holding company. These shares are no longer deemed his beneficial ownership due to changes in the holding company's governing structure. Following this adjustment, Smith …

Noticias de acciones de IDEXX Laboratories Inc (IDXX)

FedEx St. Jude Championship Director says despite changes, Memphis still on rise as golf city

The FedEx St. Jude Championship will no longer be a premier "Championship Series" event after 2027 due to PGA Tour format changes, which include splitting the schedule into a "Championship Series" and a "Challenger Series." Despite this, Executive Director Robert Miller states that Memphis …

DA Davidson Adjusts Price Target on IDEX to $240 From $230

DA Davidson has adjusted its price target on IDEX (IEX) to $240 from $230. The company currently holds an average analyst rating of overweight, with a mean price target across analysts of $250.92.

Celldex Therapeutics Inc (CLDX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Pro-Dex Inc (PDEX) Stock News Today

Barclays Forecasts Strong Price Appreciation for Celldex Therapeutics (NASDAQ:CLDX) Stock

What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate?

This article analyzes IDEXX Laboratories, Inc.'s stock price movements and valuation, utilizing a discounted cash flow (DCF) model to estimate its intrinsic value. It suggests the stock may be trading below its fair value, indicating potential for growth despite a recent price decline.

Nordex secures 525MW turbine order from Türkerler

Nordex Group has secured a contract from Türkerler Holding to supply and install wind turbines with a total capacity of approximately 525MW for a project in Türkiye. The agreement concerns the YEKA-5 R25 Sivas wind project and involves the delivery of 72 N175/6.X turbines …

IDEXX Laboratories Inc (IDXX) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Projeções de Resultados: IDEXX Laboratories Inc (IDXX) — LPA e Crescimento de Receita

Royal Bank of Canada Decreases Position in IDEX Corporation $IEX

Royal Bank of Canada reduced its stake in IDEX Corporation by 6.9% in the first quarter of 2026, selling 6,645 shares and retaining 89,664 shares valued at $17 million. Despite this reduction, institutional investors collectively own 97.96% of IDEX. The company reported strong quarterly …